Australia Radiotheranostics Market Size & Outlook, 2026-2033

Name: Australia Radiotheranostics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The radiotheranostics market in Australia is expected to reach a projected revenue of US$ 273.8 million by 2033. A compound annual growth rate of 11.8% is expected of Australia radiotheranostics market from 2026 to 2033.

Pharmaceuticals
- Radiotherapy/Nuclear Medicine
  - Radiotheranostics Market Outlook

Australia radiotheranostics radioisotope outlook (Revenue, USD million, 2021-2033)
- Iodine-131
- Iodine-123
- Gallium-68
- Lutetium-177
- 18F with Y-90
- Others
Australia radiotheranostics approach outlook (Revenue, USD million, 2021-2033)
- Targeted Therapeutic
- Targeted Diagnostic
Australia radiotheranostics application outlook (Revenue, USD million, 2021-2033)
- Oncology
  - Thyroid Cancer
  - Neuroendocrine Tumor
  - Hepatocellular Carcinoma
  - Prostate Cancer
  - Others
- Non-Oncology
  - Neurological Disorders
  - Arthritis
  - Others

Australia Radiotheranostics Market Size & Outlook, 2026-2033

Data Tree

Sign up - it's easy, and free!